Ruggiero A.,Fabbrocini G.,Cinelli E.,Megna M. Efficacy .2020 .and safety of guselkumab in psoriasis patients who failed usteki-numab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective study. Dermatol Ther, 13 : 4673.
Oliveira M.d ,Rocha B.d.O.,Duarte G.V.,Psoriasis G.V. .2015 .: Classical and emerging comorbidities. An Bras Dermatol, 10 : 20153038-20.
Mazhdrakova Z.,Tsankov I.,N. I. .2019 .Ocular changes in patients with psoriasis. Clin Dermatol, 07 : 663-667.
Chimenti M.S.,Triggianese P.,Salandri G.,Conigliaro P.,Canofari C.,Caso F.,Costa L.,Nucci C.,Aiello F.,Cesareo M. .2020 .A Multimodal Eye Assessment in Psoriatic Arthritis Patients Sine-Psoriasis: Evidence for a Potential Association with Systemic Inflammation. J Clin Med, 10 : 719.
Lam M.,Steen J.,Lu J.D.,Vender R .2020 .The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Me-taAnalysis. J Cutan Med Surg, 10 : 601-7.
Murray P.I.,Rauz S. .2016 .The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis. Best Pr Res Clin Rheumatol, 10 : 802-25.
Abbouda A.,Abicca I.,Fabiani C.,Scappatura N.,García P.P.,Scrivo R.,Priori R.,Paroli M.P.,Psoriasis Psoriatic,Arthritis-Related Uveitis .2016 .Different Ophthalmological Manifestations and Ocular Inflammation Features. Semin Ophthalmol, 1170161 : 715-20.
Van de Kerkhof P.C. ,Murphy G.M.,Austad J.,Ljungberg A.,Cambazard F.,Duvold L F. .2007 .Psoriasis of the face and flexures. J Dermatol Treat, 10 : 351-60.
Ghalamkarpour F.,Baradaran-Rafii A.,Sadoughi M.M.,Abdollahimajd F.,Younespour S.,Zargari O.,Rudolph R.I. .2019 .Ocular findings in patients with psoriasis: Is it related to the side effects of treatment or to psoriasis itself? A case-control study. J Dermatol Treat, 1577947 : 27-32.
Kilic B.,Dogan U.,Parlak A.H.,Goksugur N.,Polat M.,Serin D.,Ozmen S. .2011 .Ocular findings in patients with psoriasis. Int J Dermatol, 05424 : 4632-9.
Rehal B.,Modjtahedi B.S.,Morse L.S.,Schwab I.R.,Maibach H.I. .2010 .Ocular psoriasis. J Am Acad Dermatol, 10 : 1202-12.
Balato A.,Di A.,Patruno C.,Ayala F.,Megna M.,Balato N,Ital Dermatol Venereol G .2013 .. , 148 : 649-50.
Bernhard J.D. ,Kumar B.,Sharma V.K.,Is Eyelid V.K. .1987 .Involvement a Sign of Severe Psoriasis? /Papulonecrotic Tuberculides on Glans penis?. Dermatology, 10 : 151-2.
Cruz N.F.S.D. ,Brandão L.S.,Cruz S.F.S.D. L.S.,Cruz S.A.S.D.,Pires C.A.A.,Carneiro F.R.O. .2018 .Ocular manifestations of psoriasis. Arq Bras Oftalmol, 10 : 20180044-2749.
Aragona E.,Rania L.,Postorino E.I.,Interdonato A.,Giuffrida R.,Cannavò S.P.,Puzzolo D. .2017 .Tear film and ocular surface assessment in psoriasis. Br J Ophthalmol, 10 : 302-8.
Vadalà M.,Davì C.,Strano G.I.,Giuffrida E.,Scrivo B.,Ventura N.,Castellucci M.,Cillino S.,Cammà C.,Cappello M. .2020 .The ocular manifestations in IBD screening (OMIS) questionnaire: Pilot study on detection of ocular involvement in inflammatory bowel diseases. Int Ophthalmol, 10 : 2569-76.
Rendon A.,Schäkel K. Psoriasis,Pathogenesis K. Psoriasis .2019 .. Int J Mol Sci, 10 : 1475.
Megna M.,Fabbrocini G.,Cinelli E.,Camela E.,Ruggiero A .2020 .Guselkumab in moderate to severe psoriasis in routine clinical care: An Italian 44-week real-life experience. J Dermatol Treat, 1800577 : 1-5.
Megna M.,Fabbrocini G.,Ruggiero A.,Cinelli E .2020 .Preliminary data of a real-life 16-week retrospective study. Dermatol Ther, 10 : 4144.